Nf2 Biosolutions EIN 83-0940046

Nf2 Biosolutions FY2020 filing

EIN  83-0940046 Public charity (501(c)(3)) West Chester, PA
Form 990 (PDF)
You’re viewing the FY2020 filing — not the latest on file. See the latest (FY2024) →
Compare with another nonprofit →
Is this your organization?
Claim this profile to manage it and share your story.
Claim
Provided by the organization

This section is blank until Nf2 Biosolutions claims this page.

Know this organization? Claim it to add your story

Size
$100K–1M
What they do
Fund research and advance therapies to find a cure for NF2.
Leadership
Penny Henwood · Director
Money in and out
$708K revenue, $537K expenses
Bottom line
88% program efficiency

Fund research and advance therapies to find a cure for NF2. For fiscal year 2020 it reported $708K in revenue, $537K in expenses, and $536K in net assets.Pt I

Where the money goes · FY2020
Total revenue
$708K
Pt VIII · Ln 12
Total expenses
$537K
Pt IX · Ln 25
Net assets
$536K
Pt X · Ln 32
Revenue less expenses (Pt I · Ln 19): $171K
Where spending went · Part IX cols B–D
Program services $0.88 Management & general $0.01 Fundraising $0.10
Program efficiency
88%
of spending reaches programs
Operating runway
14.3mo
months of highly liquid reserves at operating expense rate
Surplus margin
+24%
revenue over expenses, this year

Summary of the Filing

Part I · fiscal year 2020 · Form 990
Revenue
$708K
FY2020
Expenses
$537K
FY2020
Total assets
$638K
FY2020
Total liabilities
$102K
FY2020
Total revenue
$708K
Pt VIII · Ln 12
Total expenses
$537K
Pt IX · Ln 25
Net assets
$536K
Pt X · Ln 32
Revenue less expensesPt I · Ln 19$171K
Total assetsPt X · Ln 16$638K
Program-expense ratioPt IX · col B88%
Voting members of governing bodyPt I · Ln 311
Independent voting membersPt I · Ln 4pending
Mission & Programs · Part III

Where the work happens

1 program service account for $475K of program spending, described in the organization's own filed words · FY2020.
01

The organization is funding research into a cure for NF2. The organization arranged a consortium in 2019, which was attended by leading experts in the fields of NF2 research and gene therapy.

$475Kprogram expense

Run this program? Claim this org to tell your story

Identity & Classification

Form 990 Header · IRS Business Master File
Legal nameHdr · item CNf2 Biosolutions
EINHdr · item D83-0940046
Principal addressHdr · item CWest Chester, PA
WebsiteHdr · item Jwww.nf2biosolutions.org
Year of formationHdr · item Lpending
State of legal domicileHdr · item MPA
Exempt statusHdr · item I501(c)(3) · active
NTEE classificationIRS BMFDiseases & Disorders (G20)
Ruling yearIRS BMFJul 2018

Governance & Policies

Part VI
Voting members of the governing bodyPt VI · Ln 1a11
Independent voting membersPt VI · Ln 1bpending
Conflict-of-interest policyPt VI · Ln 12aYes
Whistleblower policyPt VI · Ln 13No
Document retention policyPt VI · Ln 14No
CEO/top-official compensation independently reviewedPt VI · Ln 15aNo
Family or business relationships among officers/directorsPt VI · Ln 2Yes

Officers, Directors & Key Employees

Part VII, Section A · reportable compensation
$0Pt VII · Sec A
Director
$0Pt VII · Sec A
Director
$0Pt VII · Sec A
$0Pt VII · Sec A
Director
$0Pt VII · Sec A
Director
$0Pt VII · Sec A
Vice- President
$0Pt VII · Sec A
$0Pt VII · Sec A

Nicole Henwood’s $13K as President is at the 7th percentile of top reported officer pay among 900 $100K–1M diseases & disorders nonprofits. Peer set: organizations in the same NTEE major field of work and revenue-size band, compared on each org’s own highest-paid officer/key-employee, from Form 990 Part VII / 990-PF Part VIII. Descriptive placement, not a verdict on whether the pay is appropriate.

Compensation history total reportable pay by year · 4 named individuals · Part VII

NameFY2024FY2023FY2022
Nicole Henwood$49,600
Gilles Atlan$16,000$30,400
Nicole Henwood$12,800
Gilles Atlan$3,200

Total reportable compensation (Form 990 Part VII column D / Schedule J column E) by filing year, matched by name within this organization. The Schedule J base / bonus / deferred breakdown is not parsed into this dataset.

See Nf2 Biosolutions executive salaries →

Are you one of these people? Claim this org to confirm your role

Statement of Revenue

Part VIII
Contributions & grants100%$708K
Total revenueLn 12$708K

Statement of Functional Expenses

Part IX · allocated across program, management, and fundraising
Allocation · columns B–D
Program services $0.88 Management & general $0.01 Fundraising $0.10
Program services88%$475K
Management & general1%$7K
Fundraising10%$55K
Total functional expensesLn 25$537K

Balance Sheet

Part X · end of year
CashLn 1$638K
Total assetsLn 16$638K
Total liabilitiesLn 26$102K
Total net assetsLn 32$536K
Months of cash on handcomputed14.3

Financial Metrics

Form 990 · FY2020 · each ratio shown with the dollars behind it
Liquidity & Payout
Operating runway
Highly liquid reserves $638K · Operating expenses/yr $537K
14.3 months
Where the money goes
Program services
Program services $475K · Total expenses $537K
88%
Management & General
Management & general $7K · Total expenses $537K
1%
Fundraising
Fundraising $55K · Total expenses $537K
10%
Cost to raise $1
Fundraising expense $55K · Solicited contributions $708K
$0.08 to raise $1
Where the money comes from
Contribution dependence
Contributions & grants $708K · Total revenue $708K
100%
Government reliance
Government grants — · Total revenue $708K
Earned-income share
Program service revenue $0 · Total revenue $708K
0%
Investment reliance
Investment income $0 · Total revenue $708K
0%
Program self-sufficiency
Program service revenue $0 · Total expenses $537K
0%
Growth & trend
Revenue growth (YoY)
This year $708K · Prior year —
No prior year on file
Net-asset trend (YoY)
End of year $536K · Beginning of year —
Beginning net assets not meaningfully positive — showing dollar change
Balance sheet
Surplus Margin
Revenue $708K · Expenses $537K
+24%
Liabilities-to-Assets
Total liabilities — · Total assets $638K
Net-asset ratio
Net assets $536K · Total assets $638K
84%
Marketable Investment Share
Publicly traded securities (Pt X, ln 11) — · Other securities (Pt X, ln 12) — · Total assets (Pt X, ln 16) $638K
Excludes program-related investments (Pt X, ln 13)
People & payroll
Highest Reported Total Compensation
Individual Penny Henwood · Reported title Director · Highest reported compensation $0 · Total expenses $537K
0%
Personnel share
Salaries, benefits & payroll (Pt IX 5-10) — · Total expenses $537K
Peer comparison

Same NTEE category, revenue band, and state where available. Descriptive — not a grade.

MetricThis orgPeer medianPercentile
Program ratio 88%
Overhead ratio 1%
Fundraising cost ratio 8%
Accounting fee ratio 1%

Straight from the Form 990 — descriptive, not an evaluation. A ratio is hidden when its base is zero or too small to be meaningful; the dollars are always shown.

Grants

Schedule I · received and paid
Grants received · FY2024
See all 5 funders →
Grants paid · 24 grants · $1.7M · 2020–2024
Mass Gen Development OfficeFY2024$60,000
Yale UniversityCT · FY2024$36,351
Merlin TherapeuticsFY2024$5,791
Mulberry TherapeuticsFY2023$521,000
Mass Gen Development OfficeFY2023$60,512
Indiana UniversityIN · FY2023$47,007
Yale UniversityCT · FY2023$36,351
Williams Cancer FoundationAL · FY2023$35,436
Merlin TherapeuticsFY2023$30,200
Cell Culture Company LLCFY2023$1,838
Yale UniversityCT · FY2022$72,702
Mass Gen Development OfficeFY2022$20,000
Chop Research InstitutePA · FY2022$7,983
See all 24 grants →

Similar Organizations

Closest in mission — by what they do
See all organizations like Nf2 Biosolutions →

Compare

Search another nonprofit to view revenue, expenses, assets, key metrics, and leaders side by side

Filings & Schedule Manifest

Part IV
III · Programs I · Grants R · Related orgs G · Fundraising L · Interested persons A · Public support F · Foreign M · Noncash
FY2024 (Latest)$226K revenue · ⤓ 990 PDF
FY2023$772K revenue · ⤓ 990 PDF
FY2022$419K revenue · ⤓ 990 PDF
FY2021$544K revenue · ⤓ 990 PDF
FY2020$708K revenue · viewing · ⤓ 990 PDF

Want to add your own materials alongside these filings? Claim this org

Sources

Every figure above is drawn from these filings
Form 990 e-file (XML) · FY2020IRS
Classification, formation year, addressIRS Business Master File
Names, privacy, and removal requests More

The names, titles, and compensation shown on this page are reproduced from IRS Form 990 filings, which are public records.

Philanthropy.org does not alter the content of those filings. All information appears exactly as reported by the filing organization for the tax year shown.

We publish only information contained in the public IRS filing — and less than the filing contains. Our profile pages do not display street addresses, telephone numbers, personal email addresses, or other personal contact information, even where the filing includes them.

Many people share the same name. A name shown on this page reflects only what one organization reported in one IRS filing for one tax year. It should not be interpreted as identifying any other individual with the same or a similar name.

If you are no longer affiliated with the organization, your name will generally stop appearing in future IRS filings once the organization no longer reports you. Pages for tax years in which you were reported remain published because those filings remain part of the public record.

Philanthropy.org does not alter or remove IRS filing records. Removing a page from this website would not remove the underlying IRS filing, which remains publicly available from the IRS and other publishers of the same information.

If you believe the IRS filing itself is inaccurate, corrections must be made by the filing organization or the IRS directly.

If you ARE the filing organization, claim this org and add context

Made it to the end? Claim this organization

All figures are derived from public IRS Form 990 filings and are presented without evaluation of any organization. philanthropy.org does not rate, score, or rank organizations, including the peer-cohort and compensation comparisons above.